As shown in Figure 8B,C, relative expressions of RIPK1, RIPK3, and MLKL proteins were significantly (0.001) elevated in both HepG2 and A549 cancer cells after treatment with the IC50 of the CM derivative, when compared to the untreated cells. The gene discussed is RIPK3; the disease is cancer.